EichorEICHOR
Location: Broadmeadow Synced from ClinicalTrials.gov · August 11, 2026

Clinical studies recruiting near Broadmeadow

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) o
Phase 1 · Inipharm Australia Pty Ltd · NCT05945537
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · Genesis Research Services · Eli Lilly and Company · NCT07165028
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07221227
Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy
Phase 1 · Consano Bio Research Site · Consano Bio · NCT07264270
Patient Retrospective Outcomes (PRO)
Phase N/A · Hunter Pain Clinic · Boston Scientific Corporation · NCT01550575
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314
Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Genesis Research Services · Saluda Medical Pty Ltd · NCT04662905
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients
Phase 3 · Genesis Research Services · Doron Therapeutics Inc. · NCT07219771
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716
The RECLAIM Study.
NA · Genesis Research Services · Salvia BioElectronics · NCT06450444
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Th
Phase N/A · Hunter Clinical Research · Boston Scientific Corporation · NCT01719055
Look up another city
Look up another condition